Skip to main content

FDA recall, , Moderate risk

Philips Azurion 3, 5 and 7 Systems

Philips Azurion 3, 5 and 7 Systems: the Power Distribution Unit does not provide direct current power to essential components during a start or restart.

What to do

Check yours

If a code on your device is listed below:

  1. Check the lot against the recall notice and ask your provider or supplier before you stop using it.

Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.

What happened

Philips Medical Systems Nederland B.V. is recalling Philips Azurion systems. When a power supply failure occurs during a start or restart, the Power Distribution Unit does not provide the required direct current power to essential system components. As a result, the system does not complete the start or restart, imaging functionality is unavailable, and the system remains unavailable for clinical use.

The recall covers 2,632 units of Philips Azurion 3, 5 and 7 systems, including the Azurion 3 M12, Azurion 5 M20 and Azurion 7 B20 models. The company started the recall on its own on October 15, 2026, and told customers by letter. The products were distributed nationwide in the United States and in many other countries. The FDA classified the recall on November 18, 2026.

Is yours affected?

Match the list below, then check the codes the FDA notice also names.

  1. Philips Azurion systems

    Product details from the notice

    Philips Azurion systems. Containing the below descriptions and corresponding Model Numbers. 1. Azurion 3 M12, Model Numbers: 722063, 722221. 2. Azurion 3 M15, Model Numbers: 722064, 722222. 3. Azurion 5 M12

    Model
    • 722227

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

Distributed nationwide and in Afghanistan, Albania, Algeria, Argentina, Australia, Austria, Bangladesh, Belgium, Bolivia, Brazil, Brunei Darussal, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, French Polynesia, Germany, Ghana, Greece, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, South Korea, Kosovo, Kuwait, Lao, Latvia, Lebanon, Lithuania, Malaysia, Mexico, Mongolia, Morocco, Myanmar, Nepal, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Palestine, Panama, Peru, Philippines, Poland, Portugal, Puerto Rico, Reunion, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Syria, Taiwan, Thailand, Tunisia, Turrkiye, Turkmenistan, Ukraine, United Kingdom, United Arab Emirates, Uzbekistan, Vietnam and Yemen.

Recalled by
Philips Medical Systems Nederland B.V.Best, Netherlands
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100086
Recall number
Z-0482-2027
Quantity recalled
2,632 units
Recall type
Started by the company
How the company first told customers
Letter

All recalls from Philips Medical Systems Nederland B.V.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)

  3. Added to Recall Canary

Summary by Recall Canary, written with AI · summary updated Nov 20, 2026 · Official source: U.S. Food and Drug Administration (opens in a new tab) recall · cite: “Philips Azurion 3, 5 and 7 Systems Recall.” Recall Canary. https://recallcanary.com/recall/fda/philips-azurion-systems-2.